SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey
| dc.contributor.author | Oygar P.D. | |
| dc.contributor.author | Büyükçam A. | |
| dc.contributor.author | Bal Z.Ş. | |
| dc.contributor.author | Dalgıç N. | |
| dc.contributor.author | Bozdemir Ş.E. | |
| dc.contributor.author | Karbuz A. | |
| dc.contributor.author | Çetin B.Ş. | |
| dc.contributor.author | Kara Y. | |
| dc.contributor.author | Çetin C. | |
| dc.contributor.author | Hatipoğlu N. | |
| dc.contributor.author | Uygun H. | |
| dc.contributor.author | Aygün F.D. | |
| dc.contributor.author | Törün S.H. | |
| dc.contributor.author | Okur D.Ş. | |
| dc.contributor.author | Çiftdoğan D.Y. | |
| dc.contributor.author | Kara T.T. | |
| dc.contributor.author | Yahşi A. | |
| dc.contributor.author | Özer A. | |
| dc.contributor.author | Demir S.Ö. | |
| dc.contributor.author | Akkoç G. | |
| dc.contributor.author | Turan C. | |
| dc.contributor.author | Salı E. | |
| dc.contributor.author | Şen S. | |
| dc.contributor.author | Erdeniz E.H. | |
| dc.contributor.author | Kara S.S. | |
| dc.contributor.author | Emiroğlu M. | |
| dc.contributor.author | Erat T. | |
| dc.contributor.author | Aktürk H. | |
| dc.contributor.author | Gürlevik S.L. | |
| dc.contributor.author | Sütçü M. | |
| dc.contributor.author | Aydın Z.G.G. | |
| dc.contributor.author | Atikan B.Y. | |
| dc.contributor.author | Yeşil E. | |
| dc.contributor.author | Güner G. | |
| dc.contributor.author | Çelebi E. | |
| dc.contributor.author | Efe K. | |
| dc.contributor.author | İşançlı D.K. | |
| dc.contributor.author | Durmuş H.S. | |
| dc.contributor.author | Tekeli S. | |
| dc.contributor.author | Karaaslan A. | |
| dc.contributor.author | Bülbül L. | |
| dc.contributor.author | Almış H. | |
| dc.contributor.author | Kaba Ö. | |
| dc.contributor.author | Keleş Y.E. | |
| dc.contributor.author | Yazıcıoğlu B. | |
| dc.contributor.author | Oğuz Ş.B. | |
| dc.contributor.author | Ovalı H.F. | |
| dc.contributor.author | Doğan H.H. | |
| dc.contributor.author | Çelebi S. | |
| dc.contributor.author | Çakır D. | |
| dc.contributor.author | Karasulu B. | |
| dc.contributor.author | Alkan G. | |
| dc.contributor.author | Yenidoğan İ. | |
| dc.contributor.author | Gül D. | |
| dc.contributor.author | Küçükalioğlu B.P. | |
| dc.contributor.author | Avcu G. | |
| dc.contributor.author | Kukul M.G. | |
| dc.contributor.author | Bilen M. | |
| dc.contributor.author | Yaşar B. | |
| dc.contributor.author | Üstün T. | |
| dc.contributor.author | Kılıç Ö. | |
| dc.contributor.author | Akın Y. | |
| dc.contributor.author | Cebeci S.O. | |
| dc.contributor.author | Bucak I.H. | |
| dc.contributor.author | Yanartaş M.S. | |
| dc.contributor.author | Şahin A. | |
| dc.contributor.author | Arslanoğlu S. | |
| dc.contributor.author | Elevli M. | |
| dc.contributor.author | Çoban R. | |
| dc.contributor.author | Öz Ş.K.T. | |
| dc.contributor.author | Hatipoğlu H. | |
| dc.contributor.author | Erkum İ.T. | |
| dc.contributor.author | Turgut M. | |
| dc.contributor.author | Demirbuğa A. | |
| dc.contributor.author | Özçelik T. | |
| dc.contributor.author | Çiftçi D. | |
| dc.contributor.author | Sarı E.E. | |
| dc.contributor.author | Akkuş G. | |
| dc.contributor.author | Hatipoğlu S.S. | |
| dc.contributor.author | Dinleyici E.Ç. | |
| dc.contributor.author | Hacımustafaoğlu M. | |
| dc.contributor.author | Özkınay F. | |
| dc.contributor.author | Kurugöl Z. | |
| dc.contributor.author | Cengiz A.B. | |
| dc.contributor.author | Somer A. | |
| dc.contributor.author | Tezer H. | |
| dc.contributor.author | Kara A. | |
| dc.date.accessioned | 2025-04-10T11:05:10Z | |
| dc.date.available | 2025-04-10T11:05:10Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Background: Understanding SARS-CoV-2 seroprevalence among health care personnel is important to explore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. Methods: We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. Results: SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Conclusions: Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission. © 2021 The Author(s) | |
| dc.identifier.DOI-ID | 10.1016/j.ijid.2021.09.054 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/45877 | |
| dc.publisher | Elsevier B.V. | |
| dc.title | SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey | |
| dc.type | Article |